evista approved for breast cancer eli lilly &amp co said the food and drug administration approved evista an osteoporosis drug for prevention of breast cancer but the drug will also carry a boxed warning advising it might raise the risk of having a fatal stroke the company said evista has been approved for use by postmenopausal women at high risk for invasive breast cancer and to help ward off invasive breast cancer in postmenopausal women who have osteoporosis the boxed warning will say that a study has shown that while users didnt have a higher incidence of stroke those who had one had a higher death rate 
